Amphastar Pharmaceuticals AMPH Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's increase (decrease) in prepaid expense and other assets?
- Amphastar Pharmaceuticals (AMPH) reported increase (decrease) in prepaid expense and other assets of $2.33M in Q1 2026.
- How has Amphastar Pharmaceuticals's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Amphastar Pharmaceuticals's increase (decrease) in prepaid expense and other assets increased by 174.0% year-over-year, from $849K to $2.33M.
- What is the long-term trend for Amphastar Pharmaceuticals's increase (decrease) in prepaid expense and other assets?
- Over 2 years (2022 to 2024), Amphastar Pharmaceuticals's increase (decrease) in prepaid expense and other assets has grown at a 140.5% compound annual growth rate (CAGR), from $1.85M to $10.73M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.